Wi designed and scaled-up both hardware and disposables components, as well as executed verification and validation of the product in preparation for regulatory approvals and a successful market launch. This device was unique in that it perfused a nutrient-rich solution while maintaining precise thermal stability, thus extending organ viability for up to 72 hours. The device significantly reduces the risk of Delayed Graft Function, even in DCD (donation after cardiac death) organs. Wi, along with IDEO and Zevex, received a Medical Device Excellence Award "Gold Award" in 2004 for the platform. Another Wi therapeutic device, the LumaWave employs ultrasonic waves to soothe pain. Wi ushered development of the core technology from initial concepts through qualified production that integrated ultrasonic welding systems, proprietary flex-circuit overmolds, and produced several utility patents. Wi manufactures both industry-standard and proprietary "Blister Packs" to package and dispense diagnostic reagents and drug therapies within the point-of-care consumable form-factor. Wi offers a line of standard "off-the-shelf" solutions ranging from 50 to 1,000 µL that employ the company's trademarked Soft Open™ Blister opening and controlled dispensing methodology. Soft Open™ Blister Packs, accompanied by appropriate custom actuators, allow precise metering of dispensed fluids, thus emulating the performance of pipettes and syringes without the need for endpoint user input. Through a dedicated manufacturing process engineering team, Wi is also able to create blister packaging of virtually any practical fluid volume.